Tizanidine
NDC 67877-613, Tizanidine, tablet, from Ascend Laboratories, LLC.
- Product NDC
- 67877-613
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211798
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-613-05 | 67877061305 | 500 TABLET in 1 BOTTLE (67877-613-05) |
| 67877-613-15 | 67877061315 | 150 TABLET in 1 BOTTLE (67877-613-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/72f25135-1333-4e52-83f5-7df7d90e68bbNADAC price for package 67877061315
GET /v1/drugs/nadac/67877061315
Use it
Look up 67877-613 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-613 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-613. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.